High prevalence of anti-α-crystallin antibodies in multiple sclerosis: Correlation with severity and activity of disease

Acta Neurologica Scandinavica

Volumn 100, Issue 3, 1999, Pages 139-147

  Agius, Mark A ^a   Kirvan, C A ^a   Schafer, A L ^a   Gudipati, E ^a   Zhu, S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Multiple sclerosis; Small heat shock proteins; crystallin

Indexed keywords

ALPHA CRYSTALLIN; ANTIBODY; AUTOANTIGEN; CHAPERONE; HEAT SHOCK PROTEIN; MYELIN BASIC PROTEIN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOREACTIVITY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PATHOGENICITY;

EID: 0032790422     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1999.tb00729.x     Document Type: Article

References (25)

1. Reder AT, Arnason BGW. Immunology of multiple sclerosis. In: Vinken PJ, Bruyn GW, Klawans HL, Koestier JC, eds. Demyelinating Diseases. Handbook of Clinical Neurology. Amsterdam: Elsevier, 1985;47:337-96.
2. Link H. B cells and autoimmunity. In: Russell WC, ed. Molecular Biology of Multiple Sclerosis. New York: John Wiley & Sons, 1996:161-90.
3. DeNagel D, Pierce S. Heat shock proteins in immune responses. Crit Rev Immunol 1993;13:71-81.
4. Hartl F. Molecular chaperones in cellular protein folding. Nature 1996;381:571-80.
5. Antel J, Freedman MS. The immunologic basis for immunosuppressive and immunoregulatory therapy in multiple sclerosis. In: Herndon R, Seil F, eds. Multiple Sclerosis: Current Status of Research and Treatment. New York: Demos, 1994;157-70.
6. Birnbaum G. Stress proteins: Their role in the normal central nervous system and in disease states, especially multiple sclerosis. Springer Semin Immunopathol 1995;17:107-18.
7. Freedman MS, Buu NN, Ruus TCJ, Williams K, Antel JP. Differential expression of heat shock proteins by human glial cells. J Neuroimmunol 1992;41:231-8.
8. Srivastava PK, Peptide-binding heat shock proteins in the endoplasmic reticulum: Role in immune response to cancer and in antigen presentation. Adv Cancer Res 1993;62:153-77.
9. Ben-nun A, Mendel I, Sappler G, Kerlero de Rosbo N. A 12 kDa protein of Mycobacterium tuberculosis protects mice against experimental autoimmune encephalomyelitis. Protection in the absence of shared T cell epitopes with encephalitogenic proteins. J Immunol 1995;154:2939-48.
10. Ling Gao Y, Raine CS, Brosnan CF. Humoral response to hsp 65 in multiple sclerosis and other neurologic conditions. Neurology 1994;44:941-6.
11. Van Noort JM, van Sechel AC, Bajramovic JJ et al. The small heat shock protein αB-crystallin as candidate autoantigen in multiple sclerosis. Nature 1995;375:798-801.
12. Lowe J, McDermott H, Pike I, Spendlove I, Landon M, Mayer RJ. αB-crystallin expression in non-lenticular tissues and selective presence in ubiquinated inclusion bodies in human disease. J Path 1992;166:61-8.
13. Kato K, Shinohara H, Kurobe N, Goto S, Inaguma Y, Ohshima K. Immunoreactive αA-crystallin in rat non-lenticular tissues detected with a sensitive immunoassay method. Biochim Biophys Acta 1991;1080:173-80.
14. Horwitz J. The function of α-crystallin. Invest Ophthalmol Vis Sci 1993;34:10-22.
15. Poser CM, Paty DW, Scheinberg I, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983;13:227-31.
16. Barned S, Goodman AD, Mattson DH. Frequency of anti-nuclear antibodies in multiple sclerosis. Neurology 1995;45:384-5.
17. Blair DA, Mihovilovic M, Agius MA, Fairclough RH, Richman DP. Human X human hybridomas from patients with myasthenia gravis: Possible tools for idiotypic therapy for myasthenia. Ann NY Acad Sci 1987;505:155-60.
18. Furesz J. Serologic diagnosis of measles in subacute selerosing panencephalitis. N Engl J Med 1971;284:729-30.
19. Kinnman J, Fryden A, Eriksson S, Moller E, Link H. Tuberculous meningitis immune reactions within the central nervous system. Scand J Immunol 1981;13:289-96.
20. Martin R, Mcfarland HF, Mcfarlin DE. Immunologic aspects of demyelinating diseases. Annu Rev Immunol 1992;10:153-87.
21. Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1994;179:973-84.
22. Colombo E, Banki K, Tatum AH et al. Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis. J Clin Invest 1997;99:1238-50.
23. Selmaj KW, Brosnan CF, Raine CS. Colocalization of lymphocytes bearing gamma-delta T cell receptor and heat shock protein hsp65 oligodendrocytes in multiple sclerosis. Proc Natl Acad Sci 1991;88:6452-6.
24. Bajramovic JJ, Lassmann H, van Noort JM. Expression of alphaB-crystallin in glia cells during lesional development in multiple sclerosis. J Immunol 1997;78:143-51.
25. Guthrie TC, Nelson DA. Influence of temperature changes on multiple sclerosis: Critical review of mechanisms and research potential. J Neurol Sci 1995;129:1-8.